Atrás
Ascentage Pharma Group International (ASPHF) Ganando
Gráfico del Precio de Acciones ASPHF
ASPHF Ganando
Ascentage Pharma Group International
$8.48
0%
$0
Al cierre: Mar 23, 16:00:00 GMT-4
$8.48
0%
$0
Mercado Previo: Mar 24, 09:59:10 GMT-4
Estadísticas clave
Cierre Anterior
$8.48
Precio de apertura
$8.48
Rango del día
$8.48 - $8.48
Rango de 52 semanas
$5.82 - $10.65
Volumen
100
Volumen promedio
59
Rendimiento de dividendos
--
EPS (TTM)
-0.52
Cap. de mercado
$788.3M
¿Qué es ASCENTAGE PHARMA GROUP INTL?
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.